Radiaton Oncology 
 
 
 
 

This past year has been a year of excitement and accomplishment in the Radiation Medicine department at Saint Louis University Hospital.

We have joined a consortium to treat the early-stage prostate cancer with the CyberKnife under research protocols. Treatment is accomplished in five days, rather than nearly seven to eight weeks, and preliminary information indicates that morbidities could be much fewer than with radiation treatment, and we expect cancer centered rates to be as good as established methods. It is possible that, in a few years, CyberKnife radiosurgery will replace interstitial implants for early-stage prostate cancer.

John D. Dombrowski, MD, PhD has joined the faculty of Saint Louis University School of Medicine, and the staff at Saint Louis University Hospital. He brings many fresh ideas, and is developing a new pediatric radiation oncology service with the cooperation of Cardinal Glennon Children's Hospital.

Saint Louis University School of Medicine and Saint Louis University Hospital are partnering with Missouri Cancer Care for a second CyberKnife facility at St. Joseph’s Hospital West at Lake St. Louis. Ground has been broken, and the second CyberKnife is expected to be operational in the summer of 2008. This is a great opportunity for bridging a district gap, and should be mutually beneficial to all of the partnering entities.
We continue to strengthen multidisciplinary programs with conferences and programs cooperating with Neurosurgery, Pediatrics, Medical Oncology, Thoracic Surgery, Urology and Otolaryngology.

We are participating in several radiation oncology group protocols, including investigating patients with brain metastases, whether whole brain radiation therapy plus a CyberKnife boost, with and without chemotherapy will increase both quality and quantity of life.

Bruce J. Walz, MD, FACR Professor & Director